Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C C Sanders

Showing results (61-70 of 154) with videos related to

Pageof 16
Sort By:
American Journal of Clinical Pathology|March 11, 1975
Effects of procedural variations on the activity of aminoglycosides in vitroC C Sanders, W E Sanders
The Journal of Antimicrobial Chemotherapy|June 5, 2001
Pharmacodynamics of moxifloxacin, levofloxacin and sparfloxacin against Streptococcus pneumoniaeP D Lister, C C Sanders
American Journal of Clinical Pathology|April 1, 1980
Antagonism of cefamandole by cefoxitin in routine disk susceptibility testsC C Sanders, W E Sanders
Clinical Drug Investigation|August 14, 2016
Cefepime : The Last Generation or the First Enhanced-Potency Broad Spectrum Cephalosporin?C C Sanders, E S Moland
Antimicrobial Agents and Chemotherapy|February 1, 1991
Altered phenotypes associated with ampD mutations in Enterobacter cloacaeG Korfmann, C C Sanders, E S Moland
The Journal of Antibiotics|April 1, 1978
Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in miceR V Goering, C C Sanders, W Sanders
Antimicrobial Agents and Chemotherapy|July 1, 1991
Influence of beta-lactamase inhibitors on the potency of their companion drug with organisms possessing class I enzymesS J Cavalieri, C C Sanders, C New
Antimicrobial Agents and Chemotherapy|November 1, 1996
Efficacy of ampicillin-sulbactam is not dependent upon maintenance of a critical ratio between components: sulbactam pharmacokinetics in pharmacodynamic interactionsM Alexov, P D Lister, C C Sanders
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1993
Imipenem resistance in EnterobacterK S Thomson, C C Sanders, H Chmel
Infection and Immunity|May 1, 1977
Bacterial interference. IV. Epidemiological determinants of the antagonistic activity of the normal throat flora against group A streptococciC C Sanders, G E Nelson, W E Sanders
Pageof 16

Showing results (61-70 of 154) with videos related to

Sort By:
Pageof 16
American Journal of Clinical Pathology|March 11, 1975
Effects of procedural variations on the activity of aminoglycosides in vitroC C Sanders, W E Sanders
The Journal of Antimicrobial Chemotherapy|June 5, 2001
Pharmacodynamics of moxifloxacin, levofloxacin and sparfloxacin against Streptococcus pneumoniaeP D Lister, C C Sanders
American Journal of Clinical Pathology|April 1, 1980
Antagonism of cefamandole by cefoxitin in routine disk susceptibility testsC C Sanders, W E Sanders
Clinical Drug Investigation|August 14, 2016
Cefepime : The Last Generation or the First Enhanced-Potency Broad Spectrum Cephalosporin?C C Sanders, E S Moland
Antimicrobial Agents and Chemotherapy|February 1, 1991
Altered phenotypes associated with ampD mutations in Enterobacter cloacaeG Korfmann, C C Sanders, E S Moland
The Journal of Antibiotics|April 1, 1978
Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in miceR V Goering, C C Sanders, W Sanders
Antimicrobial Agents and Chemotherapy|July 1, 1991
Influence of beta-lactamase inhibitors on the potency of their companion drug with organisms possessing class I enzymesS J Cavalieri, C C Sanders, C New
Antimicrobial Agents and Chemotherapy|November 1, 1996
Efficacy of ampicillin-sulbactam is not dependent upon maintenance of a critical ratio between components: sulbactam pharmacokinetics in pharmacodynamic interactionsM Alexov, P D Lister, C C Sanders
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1993
Imipenem resistance in EnterobacterK S Thomson, C C Sanders, H Chmel
Infection and Immunity|May 1, 1977
Bacterial interference. IV. Epidemiological determinants of the antagonistic activity of the normal throat flora against group A streptococciC C Sanders, G E Nelson, W E Sanders
Pageof 16